SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Rose who wrote (180)1/27/2000 11:07:00 AM
From: Ron Kline  Read Replies (1) of 416
 
This is not new for this stock. Another analyst downgraded the stock on valuation when it was about $140, it went down for a week and that was that. I would never sell a stock on valuation, that's like trying to guess the tops and bottoms of the markets. One guy says it should go lower, the other says $190. These guys need to throw their weight around, that's it. Fact is MEDI is one of the few Biotech companies that has real earnings and continues to beat the street. I try not to get too caught up in this action we are seeing. Biotech is the leading group right now and MEDI will do fine. Now Wet Seal is another story.
Ron
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News